First Trust Investment Solutions L.P. Gilead Sciences, Inc. Transaction History
First Trust Investment Solutions L.P.
- $888 Billion
- Q3 2024
A detailed history of First Trust Investment Solutions L.P. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, First Trust Investment Solutions L.P. holds 43,660 shares of GILD stock, worth $3.95 Million. This represents 0.41% of its overall portfolio holdings.
Number of Shares
43,660
Previous 9,337
367.6%
Holding current value
$3.95 Million
Previous $641 Million
471.42%
% of portfolio
0.41%
Previous 0.09%
Shares
4 transactions
Others Institutions Holding GILD
# of Institutions
1,927Shares Held
994MCall Options Held
10.5MPut Options Held
9.75M-
Black Rock Inc. New York, NY121MShares$10.9 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$10.4 Billion0.18% of portfolio
-
Capital World Investors Los Angeles, CA76.5MShares$6.93 Billion1.03% of portfolio
-
Capital Research Global Investors Los Angeles, CA61.8MShares$5.59 Billion1.12% of portfolio
-
State Street Corp Boston, MA60.2MShares$5.44 Billion0.21% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $113B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...